Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019

Table of Contents
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 Hemostasis Rapid Tests & Point of Care (POC) Overview 5
3 Products under Development 6
3.1 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development 6
3.2 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory 7
3.3 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Regulatory Path 8
3.4 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Estimated Approval Date 9
4 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products under Development by Companies 10
4.1 Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development 10
4.2 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development 11
5 Hemostasis Rapid Tests & Point of Care (POC) Companies and Product Overview 12
5.1 Atomo Diagnostics Pty Ltd Company Overview 12
5.1.1 Atomo Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 12
5.2 Carclo Diagnostic Solutions Ltd Company Overview 13
5.2.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 13
5.3 Cascade Metrix LLC Company Overview 14
5.3.1 Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview 14
5.4 Edan Instruments Inc Company Overview 15
5.4.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 15
5.5 EKF Diagnostics Holdings Plc Company Overview 16
5.5.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 16
5.6 Emosis SAS Company Overview 17
5.6.1 Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview 17
5.7 Fraunhofer Institute for Cell Therapy and Immunology Company Overview 18
5.7.1 Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview 18
5.8 Helena Laboratories Corp Company Overview 19
5.8.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview 19
5.9 Universal Biosensors Inc Company Overview 26
5.9.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview 26
6 Hemostasis Rapid Tests & Point of Care (POC) - Recent Developments 27
6.1 Apr 08, 2019: Aggredyne receives FDA clearance for ADP platelet aggregation testing cartridge 27
6.2 Nov 22, 2018: EMOSIS reinforces its Intellectual Property and scientific expertise 27
7 Appendix 28
7.1 Methodology 28
7.2 About GlobalData 31
7.3 Contact Us 31
7.4 Disclaimer 31

List of Tables
Table 1: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development 6
Table 2: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory 7
Table 3: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Regulatory Path 8
Table 4: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Estimated Approval Date 9
Table 5: Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development 10
Table 6: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development 11
Table 7: Atomo Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 12
Table 10: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 13
Table 13: Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview 14
Table 16: Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 15
Table 19: EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 22: Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview 17
Table 25: Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview 18
Table 28: Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview 19
Table 47: Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 50: Glossary 30

List of Figures
Figure 1: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development 6
Figure 2: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory 7
Figure 3: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Regulatory Path 8
Figure 4: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Estimated Approval Date 9